Chemotherapy-Free Combination Therapy Targeted to the Epigenome in PTCL
Peripheral T-cell lymphoma is characterized by extensive epigenetic dysregulation.
Peripheral T-cell lymphoma is characterized by extensive epigenetic dysregulation.
Researchers report on results with CAR-T therapy in real-world populations of patients with ALL or NHL.
A literature review showed strategies for managing oral mucosal AEs in this patient population, including the role of dentists in a multidisciplinary team.
Most patients with previously untreated CLL experienced a persistent MRD benefit with a fixed-dose, obinutuzumab-ibrutinib–based treatment approach.
Currently, interpretations of FDG-PET/CT findings within the context of treatment response have not been validated in the setting of multiple myeloma.
This analysis compared the efficacy outcomes of subgroups of patients with NSCLC treated with alectinib vs crizotinib according to ALK tumor status.
Patients with Philadelphia chromosome-positive ALL were treated with dasatinib and blinatumomab during induction and consolidation therapy — without chemotherapy.
Adults treated for Hodgkin lymphoma have an increased risk of death from heart disease, interstitial lung disease, infections, and adverse effects of therapy.
Some pointers from a review of assessment and management strategies for nurses caring for patients with polycythemia vera.
A graft-vs-MDS effect of graft-vs-host disease has been observed for some patients with acute leukemia post-HSCT, but has been less well studied in those with MDS.